Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Vita Life Sciences Limited ( (AU:VLS) ) is now available.
Vita Life Sciences Limited has provided an update on its ongoing on-market share buy-back program for its ordinary fully paid shares listed on the ASX under the code VLS. The company reported that a total of 790,971 shares had been repurchased before the previous day, with an additional 9,853 shares bought back on the most recent trading day.
The notification, dated 30 March 2026, forms part of the company’s daily buy-back reporting, following the initial buy-back notification lodged in May 2025. This continued execution of the buy-back indicates an active capital management strategy that may reduce the company’s share count over time and potentially enhance value for remaining shareholders.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited is an ASX-listed company in the life sciences sector, trading under the code VLS with ordinary fully paid shares. The company operates within the broader healthcare and biotechnology investment universe, where capital management initiatives such as on-market share buy-backs are commonly used to optimise capital structure and signal confidence to investors.
Average Trading Volume: 16,342
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$141.6M
See more data about VLS stock on TipRanks’ Stock Analysis page.